141 related articles for article (PubMed ID: 33395618)
1. The clinical features, recurrence risks and surgical strategies of bone invasive pituitary adenomas.
Zhu H; Li B; Li C; Liu C; Wang X; Gui S; Zhao P; Bai J; Cao L; Zhang Y
Clin Neurol Neurosurg; 2021 Feb; 201():106455. PubMed ID: 33395618
[TBL] [Abstract][Full Text] [Related]
2. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
[No Abstract] [Full Text] [Related]
3. Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.
Rahimli T; Hidayetov T; Yusifli Z; Memmedzade H; Rajabov T; Aghayev K
World Neurosurg; 2021 May; 149():e1043-e1055. PubMed ID: 33524611
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Complications of Endoscopic Skull Base Surgery for Giant Pituitary Adenomas.
Yano S; Hide T; Shinojima N
World Neurosurg; 2017 Mar; 99():533-542. PubMed ID: 28024972
[TBL] [Abstract][Full Text] [Related]
6. Experience of trans-nasal endoscopic surgery for pituitary tumors in a single center in China: Surgical results in a cohort of 2032 patients, operated between 2006 and 2018.
Li C; Zhu H; Zong X; Wang X; Gui S; Zhao P; Bai J; Liu C; Cao L; Li Z; Zhang Y
Clin Neurol Neurosurg; 2020 Oct; 197():106176. PubMed ID: 32905978
[TBL] [Abstract][Full Text] [Related]
7. Results and risk factors for recurrence following endoscopic endonasal transsphenoidal surgery for pituitary adenoma.
Bodhinayake I; Ottenhausen M; Mooney MA; Kesavabhotla K; Christos P; Schwarz JT; Boockvar JA
Clin Neurol Neurosurg; 2014 Apr; 119():75-9. PubMed ID: 24635930
[TBL] [Abstract][Full Text] [Related]
8. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
9. Experience of Endoscopic Endonasal Approach for 803 Pituitary Tumors With Cavernous Sinus Invasion.
Zhu H; Li C; Gui S; Wang X; Zong X; Zhao P; Bai J; Liu C; Cao L; Li Z; Zhang Y
J Craniofac Surg; 2022 Mar-Apr 01; 33(2):e118-e122. PubMed ID: 34334752
[TBL] [Abstract][Full Text] [Related]
10. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
Dhandapani S; Singh H; Negm HM; Cohen S; Souweidane MM; Greenfield JP; Anand VK; Schwartz TH
J Neurosurg; 2017 Feb; 126(2):418-430. PubMed ID: 27153172
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.
Kim JH; Lee JH; Lee JH; Hong AR; Kim YJ; Kim YH
World Neurosurg; 2018 Jan; 109():e409-e416. PubMed ID: 29017983
[TBL] [Abstract][Full Text] [Related]
12. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
Koutourousiou M; Gardner PA; Fernandez-Miranda JC; Paluzzi A; Wang EW; Snyderman CH
J Neurosurg; 2013 Mar; 118(3):621-31. PubMed ID: 23289816
[TBL] [Abstract][Full Text] [Related]
14. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.
Øystese KA; Zucknick M; Casar-Borota O; Ringstad G; Bollerslev J
Endocrine; 2017 Jul; 57(1):35-45. PubMed ID: 28516382
[TBL] [Abstract][Full Text] [Related]
15. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.
Locatelli D; Veiceschi P; Castelnuovo P; Tanriover N; Evliyaoglu O; Canaz H; Ugurlar D; Gazioglu N
Childs Nerv Syst; 2019 Nov; 35(11):2119-2126. PubMed ID: 31079182
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of outcomes and learning curve of endoscopic transsphenoidal surgeries for 124 patients with pituitary adenomas].
Zhang LY; Deng K; Zhang Y; Feng M; Bao XJ; Liu XH; Xing B; Lian W; Wang RZ; Yao Y
Zhonghua Yi Xue Za Zhi; 2016 May; 96(19):1485-8. PubMed ID: 27266492
[TBL] [Abstract][Full Text] [Related]
17. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma.
Nakao N; Itakura T
J Clin Neurosci; 2011 Jan; 18(1):71-5. PubMed ID: 20851609
[TBL] [Abstract][Full Text] [Related]
19. Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre.
Asioli S; Righi A; Iommi M; Baldovini C; Ambrosi F; Guaraldi F; Zoli M; Mazzatenta D; Faustini-Fustini M; Rucci P; Giannini C; Foschini MP
Eur J Endocrinol; 2019 Feb; 180(2):127-134. PubMed ID: 30481158
[TBL] [Abstract][Full Text] [Related]
20. Transsphenoidal Surgery for Mixed Pituitary Gangliocytoma-Adenomas.
Shepard MJ; Elzoghby MA; Ghanim D; Lopes MBS; Jane JA
World Neurosurg; 2017 Dec; 108():310-316. PubMed ID: 28887280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
